Caitong International Asset Management Co., LTD Arbutus Biopharma Corp Call Options Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ABUS
# of Institutions
190Shares Held
111MCall Options Held
866KPut Options Held
608K-
Morgan Stanley New York, NY23.8MShares$73.3 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$41 Million27.3% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$35.6 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.47MShares$29.2 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.95MShares$27.6 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $462M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...